PANDORUM International Inc. has engaged EVOLUTION Life Science Partners to 
assist the company in raising capital to fund the ongoing development of its 
assets, primarily Bioengineered Liquid Cornea, advanced therapeutics to promote 
cornea regeneration. The capital would support the clinical translation of the 
first in class, first in human tissue regenerative reprogramming treatment via 
Phase 1/2a studies, along with advancing Pandorum's proprietary technology 
platform that enables production of advanced regenerative therapeutics with 
control, scalability and consistency, for cornea and beyond. While PANDORUM is 
currently engaged with USFDA for the clinical translation of its Cornea 
pipeline, the broader objective is to move from therapeutics for single tissue 
regeneration (such as, Cornea, Liver and Lung) to multi-tissue regenerative 
therapy, with the potential to extending healthy lifespan. The company is also 
exploring licensing and M&A opportunities of its assets with various 
pharmaceutical organizations, with the assistance from EVOLUTION.

PANDORUM's cofounder and CEO, Tuhin Bhowmick stated, "We are excited with this 
new partnership with EVOLUTION. Pandorum has reached an inflection point in its 
journey which will require a larger fund raise and capital market expertise. We 
believe that the partnership with EVOLUTION would help us achieve our immediate 
objective as well as the broader vision to make Regenerative Medicine a 
scalable, efficacious mainstream reality to treat millions in need across the 
world."

Neal Fischer, Managing Director at EVOLUTION stated, "The partners at EVOLUTION 
are excited about Pandorum's unique engineered exosome platform technology and 
we look forward to assisting the company in getting access to capital and 
exploring other strategic options to advance their pipeline."

EVOLUTION Life Science Partners is a life science investment bank that 
specializes in licensing, strategic advisory, M&A, and capital raising. To 
learn more about EVOLUTION, visit www.evolutionlsp.com

PANDORUM International Inc. is a regenerative medicine company with proprietary 
tissue regeneration platform. Founded in 2011 by academic entrepreneurs, 
PANDORUM has labs in San Carlos, USA and Bangalore, India. To learn more about 
PANDORUM, visit www.pandorum.com

Source - PANDORUM International Inc